Aggressive male APP23 mice modeling behavioral alterations in dementia

Behavioral Neuroscience

Volumn 120, Issue 6, 2006, Pages 1380-1383

  Vloeberghs, Ellen ^a,d   Van Dam, Debby ^a,d   Coen, Katrien ^a,d   Staufenbiel, Matthias ^b   De Deyn, Peter Paul ^a,c,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NOVARTIS PHARMA AG   (Switzerland)

^c MIDDELHEIM HOSPITAL   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Aggressive behavior; Alzheimer's disease; Isolation induced; Resident intruder; Transgenic mouse model

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

AGGRESSION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BEHAVIORAL STRESS; CAREGIVER BURDEN; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; MALE; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; TRANSGENIC MOUSE;

AGE FACTORS; AGGRESSION; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; DEMENTIA; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, TRANSGENIC; REACTION TIME; STATISTICS, NONPARAMETRIC;

EID: 33846102680     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.120.6.1380     Document Type: Article

References (26)

1. Ballard, C. G., O'Brien, J., James, I., & Swann, A. (2001). Aggression. In A. Saghal (Ed.), Dementia: Management of behavioural and psychological symptoms (pp. 61-78). Oxford, England: Oxford University Press.
2. Burns, A., Jacoby, R., & Levy, R. (1990). Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour. British Journal of Psychiatry, 157, 86-94.
3. Calhoun, M. E., Burgermeister, P., Phinney, A. L., Stalder, M., Tolnay, M., Wiederhold, K. H., et al. (1999). Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proceedings of the National Academy of Sciences, USA, 96, 14088-14093.
4. De Deyn, P. P., & Buitelaar, J. (2006). Risperidone in the management of agitation and aggression associated with psychiatric disorders. European Psychiatry, 21, 21-28.
5. De Deyn, P. P., & Katz, I. R. (2000). Control of aggression and agitation in patients with dementia: Efficacy and safety of risperidone. International Journal of Geriatric Psychiatry, 15, 14-22.
6. De Deyn, P. P., Katz, I. R., Brodaty, H., Lyons, B., Greenspan, A., & Burns, A. (2005). Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clinical Neurology and Neurosurgery, 107, 497-508.
7. Frints, S. G. M., Marynen, P., Hartmann, D., Fryns, J.-P., Steyaert, J., Schachner, M., et al. (2003). CALL interrupted in a patient with nonspecific mental retardation: Gene dosage-dependent alteration of murine brain development and behavior. Human Molecular Genetics, 12, 1463-1474.
8. Garcia-Alloza, M., Gil-Bea, F. J., Diez-Ariza, M., Chen, C. P., Francis, P. T., Lasheras, B., & Ramirez, M. J. (2005). Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia, 43, 442-449.
9. Herrmann, N., Lanctot, K. L., & Khan, L. R. (2004). The role of norepinephrine in the behavioral and psychological symptoms of dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 261-276.
10. Kumar-Singh, S., Dewachter, I., Moechars, D., Lubke, U., De Jonghe, C., Ceuterick, C., et al. (2000). Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiology of Disease, 7, 9-22.
11. Matthews, K. L., Chen, C. P., Esiri, M. M., Keene, J., Minger, S. L., & Francis, P. T. (2002). Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biological Psychiatry, 51, 407-416.
12. Miczek, K. A., Maxson, S. C., Fish, E. W., & Faccidomo, S. (2001). Aggressive behavioral phenotypes in mice. Behavioural Brain Research, 125, 167-181.
13. Minkeviciene, R., Banerjee, P., & Tanila, H. (2004). Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics, 311, 677-682.
14. Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., et al. (1999). Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. Journal of Biological Chemistry, 274, 6483-6492.
15. Moechars, D., Gilis, M., Kuiperi, C., Laenen, I., & Van Leuven, F. (1998). Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. NeuroReport, 9, 3561-3564.
16. Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., & Van Leuven, F. (1996). Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO Journal, 15, 1265-1274.
17. Raskind, M. A. (1999). Evaluation and management of aggressive behavior in the elderly demented patient. Journal of Clinical Psychiatry, 60, 45-49.
18. Reisberg, B., Borenstein, J., Salob, S. P., Ferris, S. H., Franssen, E., & Georgotas, A. (1987). Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. Journal of Clinical Psychiatry, 48, 9-15.
19. Ryden, M. B. (1988). Aggressive behavior in persons with dementia who live in the community. Alzheimer Disease & Associated Disorders, 2, 342-355.
20. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., et al. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proceedings of the National Academy of Sciences, USA, 94, 13287-13292.
21. Sturchler-Pierrat, C., & Staufenbiel, M. (2000). Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Annals of the New York Academy of Sciences, 920, 134-139.
22. Van Dam, D., D'Hooge, R., Staufenbiel, M., Van Ginneken, C., Van Meir, F., & De Deyn, P. P. (2003). Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. European Journal of Neuroscience, 17, 388-396.
23. Van Dam, D., Marescau, B., Engelborghs, S., Cremers, T., Mulder, J., Staufenbiel, M., & De Deyn, P. P. (2005). Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochemistry International, 46, 409-422.
24. Van Dam, D., Vloeberghs, E., Abramowski, D., Staufenbiel, M., & De Deyn, P. P. (2005). APP23 mice as a model of Alzheimer's disease: An example of a transgenic approach to modeling a CNS disorder. CNS spectrums, 10, 207-222.
25. Vloeberghs, E., Van Dam, D., Engelborghs, S., Nagels, G., Staufenbiel, M., & De Deyn, P. P. (2004). Altered circadian locomotor activity in APP23 mice: A model for BPSD disturbances. European Journal of Neuroscience, 20, 2757-2766.
26. Winslow, J. T., & Miczek, K. A. (1984). Habituation of aggressive behavior in mice: A parametric study. Aggressive Behavior, 10, 103-113.